Respiratory Activities
Understanding the Treatment Paradigm for Idiopathic Pulmonary Fibrosis: A Guide for the Specialty Pharmacist
0290-0000-20-217-L01-P
This live activity will review additional actions the specialty pharmacist can take to contribute to the care of patients with IPF.
9-15-2020
1.00
Overview of COVID-19: Evolving Investigational Treatment Landscape and Emerging Data
0290-0000-20-208-H01-P
This activity will provide pharmacists with a quick introduction to COVID-19, with an emphasis on recent data that are emerging on therapeutic options for the management of patients with COVID-19, as well as a brief discussion of vaccine development.
1.00
Exploring Cystic Fibrosis Management and Healthcare Economics Associated With Disease Progression
0290-0000-20-193-H01-P
This activity will examine the pathophysiology of cystic fibrosis and the complications associated with disease progression.
1.00
Idiopathic Pulmonary Fibrosis: The Specialty Pharmacist's Role in Patient Care and Population Management
0290-0000-20-189-H01-P
Through this activity, specialty pharmacists will become familiar with the current IPF treatment paradigm and receive practice pearls for improving patient care and outcomes.
1.50